First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
作者信息
Savini Helene, Bogreau Hervé, Bertaux Lionel, Bouchiba Housem, Kraemer Philippe, Parzy Daniel, Garnotel Eric, Rogier Christophe, Simon Fabrice, Pradines Bruno
出版信息
Antimicrob Agents Chemother. 2008 Jun;52(6):2283-4. doi: 10.1128/AAC.00282-08. Epub 2008 Apr 14.
Abstract
摘要
相似文献
1
First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
Antimicrob Agents Chemother. 2008 Jun;52(6):2283-4. doi: 10.1128/AAC.00282-08. Epub 2008 Apr 14.
2
First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
Antimicrob Agents Chemother. 2007 Jun;51(6):2280-1. doi: 10.1128/AAC.01532-06. Epub 2007 Apr 16.
3
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Microbes Infect. 2006 Sep;8(11):2599-604. doi: 10.1016/j.micinf.2006.07.011. Epub 2006 Aug 10.
4
In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Malar J. 2008 Jan 28;7:23. doi: 10.1186/1475-2875-7-23.
5
Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
Malar J. 2020 Jan 21;19(1):37. doi: 10.1186/s12936-020-3126-y.
6
[Atovaquone-proguanil treatment failure in Plasmodium falciparum].
Presse Med. 2011 Nov;40(11):1081-3. doi: 10.1016/j.lpm.2011.03.009. Epub 2011 May 13.
7
Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
Malar J. 2006 Apr 5;5:30. doi: 10.1186/1475-2875-5-30.
8
Atovaquone and proguanil hydrochloride for treatment of malaria.
J Travel Med. 1999 May;6 Suppl 1:S18-20.
9
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
J Antimicrob Chemother. 2006 Jan;57(1):110-5. doi: 10.1093/jac/dki420. Epub 2005 Nov 30.
10
Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
Am J Trop Med Hyg. 2007 Feb;76(2):208-23.
引用本文的文献
1
Metal(triphenylphosphine)-atovaquone Complexes: Synthesis, Antimalarial Activity, and Suppression of Heme Detoxification.
Inorg Chem. 2024 Sep 16;63(37):17087-17099. doi: 10.1021/acs.inorgchem.4c02751. Epub 2024 Aug 26.
2
Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito.
Nat Commun. 2023 Oct 12;14(1):6415. doi: 10.1038/s41467-023-42030-x.
3
The Multistage Antimalarial Compound Calxinin Perturbates Ca Homeostasis by Targeting a Unique Ion Channel.
Pharmaceutics. 2022 Jun 28;14(7):1371. doi: 10.3390/pharmaceutics14071371.
4
Molecular Surveillance for Imported Antimicrobial Resistant Plasmodium falciparum, Ontario, Canada.
Emerg Infect Dis. 2022 Apr;28(4):812-819. doi: 10.3201/eid2804.210533.
5
Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
Malar J. 2020 Jan 21;19(1):37. doi: 10.1186/s12936-020-3126-y.
6
Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
J Antimicrob Chemother. 2018 Mar 1;73(3):581-595. doi: 10.1093/jac/dkx431.
7
Plasmodium falciparum Recrudescence Two Years after Treatment of an Uncomplicated Infection without Return to an Area Where Malaria Is Endemic.
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01892-17. Print 2018 Feb.
8
Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in Nigeria.
Open Forum Infect Dis. 2014 Aug 5;1(2):ofu059. doi: 10.1093/ofid/ofu059. eCollection 2014 Sep.
9
Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.
Antimicrob Agents Chemother. 2014 Aug;58(8):4504-14. doi: 10.1128/AAC.02550-13. Epub 2014 May 27.
10
Atypical aetiology of a conjugal fever: autochthonous airport malaria between Paris and French Riviera: a case report.
Malar J. 2009 Aug 23;8:202. doi: 10.1186/1475-2875-8-202.
本文引用的文献
1
2
First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
Antimicrob Agents Chemother. 2007 Jun;51(6):2280-1. doi: 10.1128/AAC.01532-06. Epub 2007 Apr 16.
3
Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum.
Nature. 2007 Mar 1;446(7131):88-91. doi: 10.1038/nature05572.
4
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Microbes Infect. 2006 Sep;8(11):2599-604. doi: 10.1016/j.micinf.2006.07.011. Epub 2006 Aug 10.
5
Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
Am J Trop Med Hyg. 2006 Jul;75(1):146-51.
6
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas.
Am J Trop Med Hyg. 2006 Jun;74(6):953-9.
7
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
J Antimicrob Chemother. 2006 Jan;57(1):110-5. doi: 10.1093/jac/dki420. Epub 2005 Nov 30.
8
Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
Am J Trop Med Hyg. 2005 Apr;72(4):407-9.
9
Atovaquone/proguanil resistance in Africa: a case report.
Scand J Infect Dis. 2003;35(11-12):897-8.
10
Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
Clin Infect Dis. 2003 Aug 1;37(3):450-1. doi: 10.1086/375599. Epub 2003 Jul 18.
Zotero 插件